Eyal C. Attar, CHIEF MEDICAL OFFICER at Vor Biopharma Inc. (VOR), sold 2,227 shares at $1.42 ($3K) on 2025-02-13, disclosed to the SEC on 2025-02-18.
Scheduled sale ($3k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VOR | SELL | 2024-06-04 | $20K | — | Filing → |
| APRE | SELL | 2022-03-01 | $62K | — | Filing → |
| APRE | SELL | 2021-09-20 | $149K | — | Filing → |